Changing Lives through Science and Advocacy

Meet The Sabin Vaccine Institute

The Sabin Vaccine Institute is a leading nonprofit organization made up of scientists, researchers and advocates dedicated to improving the health of the world’s poorest citizens.

What We Do

Our mission is to reduce needless

suffering from vaccine-preventable

and neglected tropical diseases

by developing new vaccines,

advocating for increased access

to existing vaccines and promoting

expanded access to affordable

medical treatments.

More than 20 Years of Success

Since 1993, Sabin Vaccine Institute

(Sabin) has been at the forefront of

the global effort to reduce the burden

of vaccine-preventable diseases and

diseases that perpetuate poverty.

Our approach relies on scientific

innovation, coupled with advocacy,

communications and partnership

cultivation. From launching new

clinical trials, to leading scores of

high-level advocacy meetings, to

kick-starting public awareness

of global disease burdens, Sabin

advances the important mission of

improved global health.

Sabin Vaccine Institute was founded

to honor the legacy of Dr. Albert B.

Sabin, the developer of the oral polio

vaccine that has successfully brought

the disease to the brink of eradication.

Developing New Vaccines

Vaccines are among the most

economical and effective medical

technologies available today. Yet,

there is an urgent need for new and

more effective vaccines to fight

diseases that primarily impact those

in poverty.

Product Development Partnerships

(PDPs) provide a valuable model for

vaccine development by convening

public, private and academic partners

who each contribute something

different – from technical expertise,

to manufacturing capabilities, to

funding – to the development and

production of safe, effective vaccines.

The Sabin Vaccine Institute Product

Development Partnership (Sabin

PDP) is a leader in the field, with more

than a decade of experience in

vaccine research and development

for neglected tropical diseases that

infect hundreds of millions of people

in poor and underserved communities.

The Sabin PDP is the only partner-

ship advancing vaccine candidates

to prevent human hookworm – an

intestinal worm infection that affects

more than 700 million people around

the world. In addition, the Sabin PDP

is spearheading major vaccine research

and development projects targeting

diseases such as schistosomiasis,

severe acute respiratory syndrome

(SARS), Chagas disease, leishmaniasis,

ascariasis and trichuriasis.

Learn about our vaccine development program and the Sabin PDP partners at www.sabin.org/pdp

Promoting Immunization

Every year, vaccine-preventable

diseases cause 1.5 million child deaths

and countless cases of illness. Sabin

is dedicated to reducing the burden

and impact of vaccine-preventable

diseases, including typhoid and

paratyphoid fever, pneumococcal

disease, meningococcal disease,

human papillomavirus (HPV),

pertussis, polio, measles, rotavirus

and rubella. We also lay the ground-

work for introducing new vaccines

in endemic regions for diseases

such as dengue fever.

Technological advancements in

vaccine development are spawning

a new generation of increasingly

powerful vaccines, including

therapeutic vaccines, which have

the potential to save millions of lives

and alleviate unnecessary illness

every year. But, they must be made

available to everyone.

Education Sabin educates leaders from national

governments, the private sector,

media and civil society organizations

on the value of immunization and

encourages collaboration among all

development partners on vaccine

issues. Each year, Sabin coordinates

symposia, conferences and peer

exchanges on immunization in order

to improve global awareness, access,

policy and action.

Vaccine-preventable diseases cause 1.5 million child deaths and countless cases of illness every year.

This can and must change.

Learn more about our our work in advocacy and education at www.sabin.org/VAE

Advocacy Sabin leads a host of immunization

initiatives, including:

∞ Coalition against Typhoid

(CaT) Secretariat

∞ Dengue Vaccine Initiative

(DVI)

∞ International Association

of Immunization

Managers (IAIM)

∞ Pneumococcal Awareness

Council of Experts (PACE)

∞ ProVac International

Working Group (IWG)

∞ ROTA Council

∞ Sustainable Immunization

Financing (SIF)

Together, these initiatives help

countries make informed vaccine

policy decisions, access new vaccines

and expand disease control efforts.

We are working to expand

access to vaccines for:

∞ Typhoid

∞ Paratyphoid Fever

∞ Pneumococcal Disease

∞ Meningococcal Disease

∞ Human Papillomavirus

(HPV)

∞ Pertussis

∞ Polio

∞ Measles

∞ Rotavirus

∞ Rubella

Controlling and Eliminating Neglected Tropical Diseases

One in six people worldwide,

including more than half a billion

children, are infected with neglected

tropical diseases (NTDs). The Global

Network for Neglected Tropical

Diseases, a Sabin initiative, is working

to raise the awareness, political

will, and funding necessary to control

and eliminate the seven most

common NTDs.

These diseases cause blindness,

malnutrition and anemia, and

they create serious health risks

for women of reproductive age.

NTDs contribute to poverty

by reducing school attendance

among children and worker

productivity among adults.

The solution is within reach! For only 50 cents per person

annually, a packet of pills – donated

by the pharmaceutical companies –

can be administered to treat all seven

diseases. We work with our partners to

raise awareness of neglected tropical

diseases and help them deliver these

solutions to suffering communities.

Treatment Costs

50 Cents Per Person

Per Year

Learn more about the Global Network at www.globalnetwork.org

Seven NTDs∞ Hookworm ∞ Whipworm (ascariasis)∞ Roundworm (trichuriasis)∞ Elephantiasis

(lymphatic filariasis)∞ River Blindness

(onchocerciasis)∞ Snail Fever

(schistosomiasis)∞ Trachoma

50 ¢

What Your Contribution Means

Your support will allow us to meet

major milestones including:

• Bringingnewvaccine

candidatesthroughclinical

trials,licensureandmanufacture,

totacklediseasessuchashook-

worm,schistosomiasis,SARS,

Chagasdisease,leishmaniasis,

ascariasisandtrichuriasis.

• Reducingtheglobalprevalence

ofvaccine-preventablediseases

thatcausemorethan1.5million

childdeathseachyear

• Controllingandeliminatingthe

sevenmostcommonneglected

tropicaldiseasesthatinfectone

insixpeopleworldwideby2020

We believe that people everywhere have a right to good health that will empower them to lead successful lives. You can help us realize our vision of a world free of diseases of poverty.

Please support our mission today.

Web www.sabin.org/donateEmail donate@sabin.org

We provide strong, responsible

stewardship of donor funding.

Sabin has received Charity

Navigator’s highest four-star rating

since 2008, placing us in the top

four percent of evaluated charities, a

ranking that reflects our transparency,

accountability and efficiency.

Sabin Vaccine Institute is

a 501(c)(3) organization.

Our Tax ID number is

06-1389829.

Sabin Vaccine Institute2000 Pennsylvania Avenue, NWSuite 7100Washington, DC 20006

Phone: +1 (202) 842-5025Web: www.sabin.orgEmail: info@sabin.org

@sabinvaccine

facebook.com/sabinvaccine

Board of Trustees

Morton P. Hyman

Chairman

Founder and CEO of

MPH Enterprises, LLC

Allan L. Goldstein, Ph.D.

Professor and Emeritus Chairman

Department of Biochemistry &

Molecular Biology, The George

Washington University School

of Medicine

Rt. Hon. Baroness Helene

Hayman, GBE

Immediate Past Lord Speaker

of the House of Lords, United

Kingdom Parliament

Axel Hoos, M.D., Ph.D.

Vice President, Oncology R&D,

GlaxoSmithKline Pharmaceuticals

Michael H. Posner

Professor of Business and Society,

NYU Stern School of Business

Kevin L. Reilly

Former Chairman of the Board,

VaxGen, Inc.

Gary Rosenthal

Partner in the Sterling Group, L.P.

Immediate Past Chairman of

the Board of Trustees, Texas

Children’s Hospital

Philip K. Russell, M.D.

Past Chairman

Major General, U.S. Army Medical

Corps (Ret.)

Marc Shapiro

Non-Executive Chairman,

Chase Bank of Texas

Immediate Past Chairman of the

Board of Trustees, Baylor College

of Medicine

Peter L. Thoren

Executive Vice President,

Access Industries, Inc.

Michael E. Whitham

Secretary and Treasurer

Founding partner, Whitham,

Curtis, Christofferson & Cook

Heloisa Sabin

Honorary Trustee

Executive Leadership

Michael W. Marine,

Ambassador (Ret.)

Chief Executive Officer

Peter J. Hotez, M.D., Ph.D.

President

Director, Sabin Vaccine Institute

and Texas Children’s Hospital

Center for Vaccine Development

Ciro de Quadros, M.D., M.P.H.

Executive Vice President

Director, Vaccine Advocacy and

Education

Neeraj Mistry, M.D., M.P.H.

Managing Director

Global Network for Neglected

Tropical Diseases

Brian Davis, C.P.A.

Chief Operating Officer

Larry Ellingsworth, Ph.D.

Vice President

Deputy Director, Sabin PDP